0000950170-24-071401.txt : 20240610
0000950170-24-071401.hdr.sgml : 20240610
20240610170014
ACCESSION NUMBER: 0000950170-24-071401
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240606
FILED AS OF DATE: 20240610
DATE AS OF CHANGE: 20240610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weis Holger
CENTRAL INDEX KEY: 0001846984
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33038
FILM NUMBER: 241033587
MAIL ADDRESS:
STREET 1: C/O ZIOPHARM ONCOLOGY, INC.
STREET 2: ONE FIRST AVENUE, PARRIS BLDG 34
CITY: BOSTON
STATE: MA
ZIP: 02129
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alaunos Therapeutics, Inc.
CENTRAL INDEX KEY: 0001107421
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 841475642
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2617 BISSONNET ST
STREET 2: SUITE 225
CITY: HOUSTON
STATE: TX
ZIP: 77005
BUSINESS PHONE: (346) 355-4099
MAIL ADDRESS:
STREET 1: 2617 BISSONNET ST
STREET 2: SUITE 225
CITY: HOUSTON
STATE: TX
ZIP: 77005
FORMER COMPANY:
FORMER CONFORMED NAME: ZIOPHARM ONCOLOGY INC
DATE OF NAME CHANGE: 20050919
FORMER COMPANY:
FORMER CONFORMED NAME: EASYWEB INC
DATE OF NAME CHANGE: 20010213
4
1
ownership.xml
4
X0508
4
2024-06-06
0001107421
Alaunos Therapeutics, Inc.
TCRT
0001846984
Weis Holger
C/O ALAUNOS THERAPEUTICS, INC.
2617 BISSONNET ST, SUITE 225
HOUSTON
TX
770005
true
false
false
false
false
Employee Stock Option (right to buy)
1.03
2024-06-06
4
A
false
19200
0.00
A
2034-06-05
Common Stock
19200
19200
D
Employee Stock Option (right to buy)
1.03
2024-06-06
4
A
false
4524
0.00
A
2034-06-05
Common Stock
4524
4524
D
One-twelfth of the Option vests each month on the monthly anniversary of June 6, 2024, with any amount that remains unvested on the date immediately preceding the Company's 2025 annual general meeting of stockholders vesting thereon.
These options are fully vested as of June 6, 2024.
/s/ Melinda Lackey, Attorney-in-Fact
2024-06-10